Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Pre-pilot study:
- People who are 18 years of age or older
- People who are currently menstruating
Main study:
- People who carry a confirmed or likely harmful genetic change in one of these genes: MLH1, MSH2, MSH6, PMS2, or EPCAM (known as Lynch syndrome)
- People who are 18 years of age or older
- People who have a planned uterine lining biopsy (a routine screening procedure) already scheduled
- People who are currently menstruating
- People who are able to give informed consent to participate
Who may not be able to join:
Pre-pilot study:
- People who currently have a levonorgestrel-releasing IUD (a type of hormonal contraceptive device) in place, or who had one removed within the 30 days before sample collection
- People who have previously had an endometrial ablation (a procedure that removes the uterine lining)
- People with a personal history of uterine lining cancer or a pre-cancerous condition of the uterine lining
- People with a known inherited gene change in MLH1, MSH2, MSH6, PMS2, or EPCAM
- People with a known allergy to silicone (the material used in menstrual cups)
Main study:
- People who are currently pregnant
- People who currently have a levonorgestrel-releasing IUD in place, or who had one removed within the 30 days before sample collection
- People who have previously had an endometrial ablation
- People with a personal history of uterine lining cancer
- People with a known allergy to silicone (the material used in menstrual cups)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jessica D St. Laurent, MD, Brigham and Women's Hospital
Phone: 857-215-1892
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of samples considered adequate for pathologic evaluation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.